Magnetic resonance imaging screening in women at genetic risk of breast cancer: Imaging and analysis protocol for the UK multicentre study

Magnetic Resonance Imaging

Volumn 18, Issue 7, 2000, Pages 765-776

  Brown, J ^a   Buckley, D ^b   Coulthard, A ^c   Dixon, A K ^d   Dixon, J M ^e   Easton, D F ^f   Eeles, R A ^g   Evans, D G R ^h   Gilbert, F G ⁱ   Graves, M ^d   Hayes, C ^g   Jenkins, J P R ^j   Jones, A P ^k   Keevil, S F ^l   Leach, M O ^g   Liney, G P ^m   Moss, S M ⁿ   Padhani, A R ^g   Parker, G J M ^o   Pointon, L J ^g   Ponder, B A J ^d   Redpath, T W ⁱ   Sloane, J P ^p   Turnbull, L W ^m   Walker, L G ^q   Warren, R M L ^d   more..

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h ST MARY S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^k CHRISTIE HOSPITAL   (United Kingdom)

^l KING'S COLLEGE LONDON   (United Kingdom)

^m HULL ROYAL INFIRMARY   (United Kingdom)

ⁿ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^o UNIVERSITY COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF LIVERPOOL   (United Kingdom)

^q UNIVERSITY OF HULL   (United Kingdom)

more..

Author keywords

Breast cancer; Contrast agent; Genetic predisposition; Mammography; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; GENETIC RISK; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0033776831     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(00)00167-3     Document Type: Article

References (47)

1. Genetic linkage analysis in familial breast and ovarian cancer; Results from 214 families
2. Follow-up study of 24 families with Li-Fraumeni syndrome
3. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
4. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
5. European Society of Mastology Consensus Conference on breast cancer screening: Report of the evaluation committee
6. Cancers detected and induced in mammographic screening: New screening schedules and younger women with family history
7. Rationale for a National Multi-Centre Study of Magnetic Resonance Imaging (MRI) Screening in Women at Genetic Risk of Breast Cancer
8. Protocol for a national multi-centre study of magnetic resonance imaging (MRI) screening in women at genetic risk of breast cancer
9. Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions
10. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast
11. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis
12. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
13. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast
14. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency
15. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique
16. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA
17. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles
18. Contrast-enhanced magnetic resonance imaging of the breast
19. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging
20. Dynamic contrast-enhanced MR imaging of the breast combined with pharmacokinetic analysis of Gd-DTPA uptake in the diagnosis of recurrence of early-stage breast carcinoma
21. Menstrual cycle and age: Influence on parenchymal contrast medium enhancement in MR imaging of the breast
22. Localization of breast lesions shown only on MRI - A review for the UK study of MRI screening for breast cancer
23. Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast
24. Nonpalpable breast tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
25. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI
26. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
27. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
28. Multifeature analysis of Gd-enhanced MR images of breast lesions
29. Lesion Diagnosis Working Group Lesion diagnosis working group report
30. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: Preliminary experience
31. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI
32. Incorporation of washin and washout criteria for improvement of specificity in dynamic gadolinium-enhanced MRI of breast lesions
33. Correlation between contrast enhancement in dynamic MRI of the breast and tumour angiogenesis
34. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
35. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions
36. Choice of contrast enhancement index for dynamic magnetic resonance mammography
37. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
38. Rapid calculation of T1 using variable flip angle gradient refocused imaging
39. The UK MRI breast screening study advisory group. Quality assurance in the UK multi-centre study of MRI screening for breast cancer
40. Assessment of several quantitative measurements of dynamic contrast-enhanced MRI in the differentiation of primary breast tumours
41. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR Imaging 1. Fundamental concepts
42. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR Imaging
43. Dynamic MR Mammography: A comparison of two pharmacokinetic modelling techniques
44. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
45. The UK MRI breast screening study advisory group A breast phantom for quality assurance in a multi-centre screening trial